Asia-Pacific long read sequencing market is projected to register a healthy CAGR in the forecast period of 2020 to 2027. The new market report contains data for the historic year 2018, the base year of calculation is 2019 and the forecast period is 2020 to 2027.
Market Segmentation:
Asia-Pacific Long Read Sequencing Market, By Technology (Single- Molecule Real- Time Sequencing, Nanopore Sequencing, Synthetic Long Read Sequencing and Others), Product (Instruments, Consumables and Services), Application (Whole Genome Sequencing, Epigenetics, RNA Sequencing, Complex Population, Targeted Sequencing and Others), Workflow (Pre-Sequencing, Sequencing and Data Analysis), End-user (Academic & Research Institutes, Clinical Laboratories, Hospitals, Pharma & Biotech Entities and Others), Distribution Channel (Direct Tender and Retail Sales), Country (Japan, China, South Korea, India, Australia, Singapore, Thailand, Malaysia, Indonesia, Philippines and rest of Asia Pacific) Industry Trends and Forecast to 2027

Some of the major factors contributing to the growth of the Asia-Pacific long read sequencing market are:

• Increasing application in clinical sequencing & analysis
• Rising prevalence of genetic disorders
Market Players:

The key market players for Asia-Pacific long read sequencing market are listed below:

• Illumina, Inc.
• Thermo Fisher Scientific Inc.
• Oxford Nanopore Technologies
• PerkinElmer Inc.
• Novogene Corporation
• Pacific Biosciences of California, Inc.
• Agilent Technologies, Inc.
• BGI
• GENEWIZ Inc. (A subsidiary of Brooks Automation, Inc.)
• Longas Technologies
• Lexogen GmbH
• Macrogen, Inc.
• Promega Corporation
• QIAGEN
• Takara Bio Inc.